Publicaciones en colaboración con investigadores/as de University of Montreal (11)

2023

  1. A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials

    Med, Vol. 4, Núm. 10, pp. 710-727.e5

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry

    American Journal of Human Genetics, Vol. 110, Núm. 7, pp. 1200-1206

2022

  1. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score

    Prostate cancer and prostatic diseases, Vol. 25, Núm. 4, pp. 755-761

2021

  1. COVID-19 pandemic and its impact on the management of head and neck cancer in the spanish healthcare system

    International Archives of Otorhinolaryngology, Vol. 25, Núm. 4, pp. E610-E615

  2. Marital status and prostate cancer incidence: a pooled analysis of 12 case–control studies from the PRACTICAL consortium

    European Journal of Epidemiology, Vol. 36, Núm. 9, pp. 913-925

  3. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0)

    Nature Genetics

  4. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    Nature Genetics, Vol. 53, Núm. 1, pp. 65-75

2019

  1. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    American Journal of Human Genetics, Vol. 104, Núm. 1, pp. 21-34

2017

  1. Association analysis identifies 65 new breast cancer risk loci

    Nature, Vol. 551, Núm. 7678, pp. 92-94

  2. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

    Nature Genetics, Vol. 49, Núm. 12, pp. 1767-1778